Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A Yale study has developed a promising norovirus vaccine using the virus's own RNA structure as a blueprint — and it worked in mice, even immunocompromised ones. The approach targets structural "hotspots" in the viral genome to weaken the virus while triggering a broad immune response. Best part? The technique could potentially be applied to any RNA virus with a known sequence.
Yale researchers have developed a novel norovirus vaccine strategy that exploits the structural features of the virus's RNA genome — and the results, published in Cell, are turning heads. By identifying and disrupting key structural "hotspots" in the norovirus genome, the team created a weakened "mutant" virus that not only limits infection but also triggers an immune response capable of neutralizing the normal virus. Crucially, it worked even in immunocompromised mice.
What makes this especially exciting is the broader potential. Unlike mRNA vaccines — which target a single protein — this approach stimulates immunity against all viral proteins. And since it works with any virus whose genomic sequence is known, it could be a game-changer for rapidly developing vaccines against emerging RNA pathogens. Researchers are now working toward a human norovirus vaccine.
By the Numbers:
Why it matters: Norovirus has long evaded vaccination efforts, and this structural RNA approach offers a new path forward — not just for norovirus, but potentially for the next unknown RNA virus to emerge.
